Joaquim Trias
Oprichter bij Arixa Pharmaceuticals, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Eric M. Gordon | M | 78 |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA.
Arixa Pharmaceuticals, Inc.
 Arixa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arixa Pharmaceuticals, Inc. engages in the development of oral antibiotics for resistant gram-negative infections. The company was founded by Eric Gordon, John Gordon Freund, and Joaquim Trias in 2016 and is headquartered in Palo Alto, CA. | 10 jaar |
| Edward Doherty | M | - |
Attivare Therapeutics, Inc.
 Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Attivare Therapeutics, Inc. develops biomaterial vaccines. The company is based in Natick, MA. The company was founded by Edward Doherty. The CEO is Joaquim Trias. | - |
| Jessica McDonough | F | - |
Attivare Therapeutics, Inc.
Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Attivare Therapeutics, Inc. develops biomaterial vaccines. The company is based in Natick, MA. The company was founded by Edward Doherty. The CEO is Joaquim Trias. | - |
| Carlos Alberto Arias Antun | M | - |
iMiCROQ SL
 iMiCROQ SL Medical SpecialtiesHealth Technology iMiCROQ SL develops pathogen detection systems for the food safety industry. Its diagnostic systems test for the presence of listeria, staphylococcus, salmonella, and airborne contaminants. The company was founded by Carlos Arias, Viviana Duarte, Diego Bejarano, Pablo Lozano, and Ioanis Katakis on April 23, 2010, and is headquartered in Tarragona, Spain. | 14 jaar |
| Diego Bejarano Nosas | M | - |
iMiCROQ SL
iMiCROQ SL Medical SpecialtiesHealth Technology iMiCROQ SL develops pathogen detection systems for the food safety industry. Its diagnostic systems test for the presence of listeria, staphylococcus, salmonella, and airborne contaminants. The company was founded by Carlos Arias, Viviana Duarte, Diego Bejarano, Pablo Lozano, and Ioanis Katakis on April 23, 2010, and is headquartered in Tarragona, Spain. | 14 jaar |
| Pablo Lozano Sanchez | M | - |
iMiCROQ SL
iMiCROQ SL Medical SpecialtiesHealth Technology iMiCROQ SL develops pathogen detection systems for the food safety industry. Its diagnostic systems test for the presence of listeria, staphylococcus, salmonella, and airborne contaminants. The company was founded by Carlos Arias, Viviana Duarte, Diego Bejarano, Pablo Lozano, and Ioanis Katakis on April 23, 2010, and is headquartered in Tarragona, Spain. | 14 jaar |
| Adrian Curran | M | - |
Adan Medical Innovation SL
 Adan Medical Innovation SL Medical SpecialtiesHealth Technology Adan Medical Innovation SL is a Spanish company that aims to increase education and awareness about anaphylaxis and its treatment to prevent fatal outcomes. Adan Medical Innovation is based in Bilbao, ES. The company has developed Allergobox, a smart medical device connected to a telecontrol platform that helps manage autoinjectors of adrenaline to treat anaphylaxis in public spaces. The concept of Alergoprotección was created to protect public spaces against fatal outcomes of severe allergic reactions and to raise awareness about anaphylaxis. The company's mission is to improve the quality of life of patients who suffer from severe allergic reactions. The company was founded in 2013 by Adrian Curran, Anna Sala. Xavier Guillem has been the CEO of the company since 2015. | 11 jaar |
| Anna Sala | M | - |
Adan Medical Innovation SL
Adan Medical Innovation SL Medical SpecialtiesHealth Technology Adan Medical Innovation SL is a Spanish company that aims to increase education and awareness about anaphylaxis and its treatment to prevent fatal outcomes. Adan Medical Innovation is based in Bilbao, ES. The company has developed Allergobox, a smart medical device connected to a telecontrol platform that helps manage autoinjectors of adrenaline to treat anaphylaxis in public spaces. The concept of Alergoprotección was created to protect public spaces against fatal outcomes of severe allergic reactions and to raise awareness about anaphylaxis. The company's mission is to improve the quality of life of patients who suffer from severe allergic reactions. The company was founded in 2013 by Adrian Curran, Anna Sala. Xavier Guillem has been the CEO of the company since 2015. | 11 jaar |
| Fernanda Langellotto | F | - |
Attivare Therapeutics, Inc.
Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Attivare Therapeutics, Inc. develops biomaterial vaccines. The company is based in Natick, MA. The company was founded by Edward Doherty. The CEO is Joaquim Trias. | - |
| Ben Seiler | M | - |
Attivare Therapeutics, Inc.
Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Attivare Therapeutics, Inc. develops biomaterial vaccines. The company is based in Natick, MA. The company was founded by Edward Doherty. The CEO is Joaquim Trias. | - |
| Richard J. White | M | 82 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 27 jaar |
| Jennifer D. Copeland | F | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 20 jaar |
| Sergio Martinez Montequin | M | - |
iMiCROQ SL
iMiCROQ SL Medical SpecialtiesHealth Technology iMiCROQ SL develops pathogen detection systems for the food safety industry. Its diagnostic systems test for the presence of listeria, staphylococcus, salmonella, and airborne contaminants. The company was founded by Carlos Arias, Viviana Duarte, Diego Bejarano, Pablo Lozano, and Ioanis Katakis on April 23, 2010, and is headquartered in Tarragona, Spain. | - |
| Muhammedi Zeshan | M | - |
Attivare Therapeutics, Inc.
Attivare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Attivare Therapeutics, Inc. develops biomaterial vaccines. The company is based in Natick, MA. The company was founded by Edward Doherty. The CEO is Joaquim Trias. | 3 jaar |
| Xavier Guillem | M | - |
Adan Medical Innovation SL
Adan Medical Innovation SL Medical SpecialtiesHealth Technology Adan Medical Innovation SL is a Spanish company that aims to increase education and awareness about anaphylaxis and its treatment to prevent fatal outcomes. Adan Medical Innovation is based in Bilbao, ES. The company has developed Allergobox, a smart medical device connected to a telecontrol platform that helps manage autoinjectors of adrenaline to treat anaphylaxis in public spaces. The concept of Alergoprotección was created to protect public spaces against fatal outcomes of severe allergic reactions and to raise awareness about anaphylaxis. The company's mission is to improve the quality of life of patients who suffer from severe allergic reactions. The company was founded in 2013 by Adrian Curran, Anna Sala. Xavier Guillem has been the CEO of the company since 2015. | 9 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| John Freund | M | 70 |
Arixa Pharmaceuticals, Inc.
Arixa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arixa Pharmaceuticals, Inc. engages in the development of oral antibiotics for resistant gram-negative infections. The company was founded by Eric Gordon, John Gordon Freund, and Joaquim Trias in 2016 and is headquartered in Palo Alto, CA. | 4 jaar |
| Dov Goldstein | M | 56 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 15 jaar |
| David Milligan | M | 83 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 8 jaar |
| George F. Horner | M | 80 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 9 jaar |
| Paul Truex | M | 55 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 jaar |
| Martin Stogniew | M | 69 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Cheryl A. Wenzinger | F | 75 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| David S. Krause | M | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 3 jaar |
| Thomas Hess | M | 60 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 2 jaar |
| Linda E. Wiesinger | F | 70 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 2 jaar |
| James Cavanaugh | M | 87 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | - |
| Alan Dunton | M | 70 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 jaar |
| Dinesh Patel | M | 67 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 7 jaar |
| Steven Gelone | M | 56 |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | 1 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 22 | 75.86% |
| Spanje | 7 | 24.14% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Joaquim Trias
- Persoonlijk netwerk
